cytomegalovirus vaccine (MUbio Products BV)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namecytomegalovirus vaccine (MUbio Products BV)

Drug Alias NameCMV triple antigen (MUbio Products BV)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCytomegalovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMUbio Products BV

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMUbio Products BV

Active IndicationsN/A

Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A